Heparin and Oversulfated Heparin Byproduct Induce Thrombin Generation Through Contact System Activation in Plasma of Patients With HIT

Abstract

Heparin-induced thrombocytopenia with thrombosis (HITT) is the most severe side effect of heparin administration. Patients with HITT may die or have permanent sequelae such as stroke or limb amputation. Contaminated heparin is associated with anaphylactic reactions and deaths by activating the contact system. It is also associated with high incidence of HIT via a yet unknown mechanism. This study showed that although oversulfated heparin byproduct induced thrombin activities in both normal and HIT patient plasmas through the contact system activation, authentic heparin induced thrombin activities only in HIT patient plasmas containing autoantibodies against protein/ heparin complex. These data suggest that the negatively charged immunoglobulin G (IgG)/platelet factor 4 (PF4)/heparin complex activate the contact system and produce thrombin in human plasma, and thrombin partially activates the platelets allowing subsequent platelet activation through IgG/Fc receptor II signaling. The newly discovered mechanism of heparin-induced thrombin activity could explain the increased incidence of HIT in patients exposed to contaminated heparin. Furthermore, the assays used in these studies would be valuable for HIT diagnosis, prevention, and treatment.

Keywords

contaminated heparin contact system thrombin kallikrein heparin-induced thrombocytopenia

References

Warkentin TE , Levine MN , Hirsh J. , et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin . N Engl J Med. 1995;332(20):1330-1335.

Comunale ME , Van Cott EM Heparin-induced thrombocytopenia. Int Anesthesiol Clin. 2004;42(3):27-43.

Greinacher A, Warkentin TE. Contaminated heparin. N Engl J Med. 2008;359(12):1291-1292. author reply 3.

Tardy-Poncet B. , Piot M. , Chapelle C. , et al. Thrombin generation and heparin-induced thrombocytopenia (HIT). J Thromb Haemost. 2009;7(9):1474-1481.

Cines DB , Rauova L. , Arepally G. , et al. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly. J Clin Apher . 2007;22(1):31-36.

Coughlin SR Protease-activated receptors and platelet function. Thromb Haemost. 1999;82(2):353-356.

Kelton JG , Warkentin TE Heparin-induced thrombocytopenia: a historical perspective. Blood. 2008;112(7): 2607-2616.

Adiguzel C. , Bansal V. , Litinas E. , et al. Increased prevalence of antiheparin platelet factor 4 antibodies in patients may be due to contaminated heparin. Clin Appl Thromb Hemost. 2009;15(2):145-151.

Kishimoto TK , Viswanathan K. , Ganguly T. , et al. Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System. N Engl J Med. 2008;358(23):2457-2467.

10.

Blossom DB , Kallen AJ , Patel PR , et al. Outbreak of Adverse Reactions Associated with Contaminated Heparin . N Engl J Med. 2008;359(25):2674-2684.

11.

Waaler BA Contact activation in the intrinsic blood clotting system: studies on a plasma product formed on contact with glass and similar surfaces. Scand J Clin Lab Invest. 1959;11(suppl 37):1-133.

12.

Colman RW Contact activation (kallikrein-kinin) pathway: multiple physiologic and pathophysiologic activities. In: Colman RW , ed. Hemostasis and Thrombosis. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:107-130.

13.

Qian Y. , Pan J. , Zhou X. , et al. Oversulfated heparin byproducts induce thrombin generation through contact system activation. Clin Appl Thromb Hemost. Accepted 2009.

14.

Pan J. , Qi Y. , Zhou X. , Lu H. , Ramacciotti E. , Zhang L. Chemically oversulfated heparin byproducts are potent modulators of contact system activation and cell signaling. J Biol Chem. Accepted in principle 2009.

15.

Pan J. , Qian Y. , Zhou X. , et al. Oversulfated Chondroitin sulfate is not the Sole Contaminant in Heparin. Nature Biotechnology, accepted, 2010.

16.

Meyer T. , Robles-Carrillo L. , Robson T. , et al. Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice. J Thromb Haemost. 2009;7(1):171-181.

17.

Amiral J. , Marfaing-Koka A. , Wolf M. , et al. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood. 1996;88(2):410-416.

18.

Zhang L. , Beeler DL , Lawrence R. , et al. 6-Osulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway. J Biol Chem. 2001;276(45):42311-42321.

19.

Greinacher A. , Gopinadhan M. , Gunther JU , et al. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies. Arterioscler Thromb Vasc Biol. 2006;26(10):2386-2393.

20.

Studelska DR , Mandik-Nayak L. , Zhou X. , et al. High affinity glycosaminoglycan and autoantigen interaction explains joint specificity in a mouse model of rheumatoid arthritis. J Biol Chem. 2009;284(4):2354-2362.

21.

Akilesh S. , Jendrisak M. , Zhang L. , Lewis JS Jr , Liapis H. Acute renal allograft thrombosis in ‘seronegative’ antiphospholipid syndrome. NDT Plus. 2009;2(2):181-182.

22.

Newman PM , Chong BH Heparin-induced thrombocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. Blood. 2000; 96(1):182-187.

23.

Shelat SG , Tomaski A. , Pollak ES Serologic results in >1000 patients with suspected heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 2008;14(4): 410-414.